CLS Holdings USA, Inc. (OTCQB: CLSH) (CLS Holdings, Inc.), also known as Cannabis Life Sciences, does not want to lose sight of how its product can ultimately help people as they expand their market share. Jeffrey Binder, Chairman and Chief Executive Officer of CLS, tells Stock Day’s Everett Jolly there are many opportunities on the horizon.
“There are a lot of applications for [medical marijuana] where it can be beneficial,” says Binder. He then pointed to the example of Colorado where medical marijuana has been used successfully for years. “People are actually flocking to the state,” he explained.
He and Jolly discussed the stats that indicate opioid addiction, in states with medical marijuana, are actually down. On a more personal note, Binder also highlighted other medical uses.
“One of the reason’s I’m in this business is because my Godchild was diagnosed autistic. With early intervention and a dietary supplement, she has mainstreamed in school. She’ll be 8-years-old.” He added, “I don’t want us in the industry to lose sight of the benefits of medical marijuana.”
Jolly then turned to CLS’s recent letters of intent towards two businesses in Massachusetts; indications they are looking to expand.
“We looked to Massachusetts where there are only 39 medical licenses,” explained Binder. “We believe that there will be a very limited number offered by the state. So, we see that as a great opportunity to garner market share.”
Binder told Jolly that CLS has agreed in principle to loan $5 million to In Good Health, a licensed medical dispensary in Brockton. Along with the loan, CLS will have an option to acquire In Good Health. Also, CLS has also agreed in principle to form an 80/20 joint venture with CannAssist, which CLS will own 80%. CannAssist plans to build out a recreationally licensed cultivation grow facility in Leicester.
To hear more about CLS’ future plans, listen to the podcast here: https://upticknewswire.com/featured-interview-ceo-jeffrey-binder-of-cls-holdings-usa-inc-otcqb-clsh-3/